OZEM ETF (Roundhill GLP-1 & Weight Loss ETF) is managed by Roundhill Investments with $49.7M in net assets. OZEM expense ratio is 0.59%, holding 28 positions across sectors including Health Care, Unknown, Financials. Inception date: 2024-05-21.

OZEM performance shows a YTD return of -11.51%. The 1-year return is 29.73%. OZEM dividend yield stands at 1.29%, paid annually.

OZEM top holdings include Eli Lilly and Co. (15.3%), Novo Nordisk A/S Cl B (14.8%), Pfizer Inc Common Stock Usd 0.05 (7.2%), Viking Therapeutics Inc (5.4%), Ascletis Pharma Inc. (5.1%). View all OZEM holdings, sector breakdown, or dividend history.

OZEM can be compared against other funds using the overlap calculator or side-by-side comparison tool. OZEM alternatives are available via the screener, along with tax-loss harvesting opportunities.